Literature DB >> 21901713

Acupuncture for pain in endometriosis.

Xiaoshu Zhu1, Kindreth D Hamilton, Ewan D McNicol.   

Abstract

BACKGROUND: Endometriosis is a prevalent gynaecological condition, significantly affecting women's lives. Clinical presentations may vary from absence of symptoms to complaints of chronic pelvic pain, most notably dysmenorrhoea. The management of pain in endometriosis is currently inadequate. Acupuncture has been studied in gynaecological disorders but its effectiveness for pain in endometriosis is uncertain.
OBJECTIVES: To determine the effectiveness and safety of acupuncture for pain in endometriosis. SEARCH STRATEGY: We searched the Cochrane Menstrual Disorders and Subfertility Group (MSDG) Specialised Register of controlled trials, Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library), MEDLINE, EMBASE, CINAHL, AMED, PsycINFO, CNKI and TCMDS (from inception to 2010) and reference lists of retrieved articles. SELECTION CRITERIA: Randomised single or double-blind controlled trials enrolling women of reproductive age with a laparoscopically confirmed diagnosis of endometriosis and comparing acupuncture (body, scalp or auricular) to either placebo or sham, no treatment, conventional therapies or Chinese herbal medicine. DATA COLLECTION AND ANALYSIS: Three authors independently assessed risk of bias and extracted data; we contacted study authors for additional information. Meta-analyses were not performed as only one study was included. The primary outcome measure was decrease in pain from endometriosis. Secondary outcome measures included improvement in quality of life scores, pregnancy rate, adverse effects and rate of endometriosis recurrence. MAIN
RESULTS: Twenty-four studies were identified that involved acupuncture for endometriosis; however only one trial, enrolling 67 participants, met all the inclusion criteria. The single included trial defined pain scores and cure rates according to the Guideline for Clinical Research on New Chinese Medicine. Dysmenorrhoea scores were lower in the acupuncture group (mean difference -4.81 points, 95% confidence interval -6.25 to -3.37, P < 0.00001) using the 15-point Guideline for Clinical Research on New Chinese Medicine for Treatment of Pelvic Endometriosis scale. The total effective rate ('cured', 'significantly effective' or 'effective') for auricular acupuncture and Chinese herbal medicine was 91.9% and 60%, respectively (risk ratio 3.04, 95% confidence interval 1.65 to 5.62, P = 0.0004). The improvement rate did not differ significantly between auricular acupuncture and Chinese herbal medicine for cases of mild to moderate dysmenorrhoea, whereas auricular acupuncture did significantly reduce pain in cases of severe dysmenorrhoea. Data were not available for secondary outcomes measures. AUTHORS'
CONCLUSIONS: The evidence to support the effectiveness of acupuncture for pain in endometriosis is limited, based on the results of only a single study that was included in this review. This review highlights the necessity for developing future studies that are well-designed, double-blinded, randomised controlled trials that assess various types of acupuncture in comparison to conventional therapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901713     DOI: 10.1002/14651858.CD007864.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  23 in total

1.  National German Guideline (S2k): Guideline for the Diagnosis and Treatment of Endometriosis: Long Version - AWMF Registry No. 015-045.

Authors:  U Ulrich; O Buchweitz; R Greb; J Keckstein; I von Leffern; P Oppelt; S P Renner; M Sillem; W Stummvoll; R-L De Wilde; K-W Schweppe
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-12       Impact factor: 2.915

Review 2.  Integrating acupuncture: are there positive health outcomes for women?

Authors:  Nicola Robinson
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

3.  Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469-776.

Authors:  Christopher James Sampson; David George Thomas Whitehurst; Andrew Street
Journal:  Eur J Health Econ       Date:  2013-03-15

4.  Interdisciplinary S2k Guidelines for the Diagnosis and Treatment of Endometriosis: Short Version - AWMF Registry No. 015-045, August 2013.

Authors:  U Ulrich; O Buchweitz; R Greb; J Keckstein; I von Leffern; P Oppelt; S P Renner; M Sillem; W Stummvoll; K-W Schweppe
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

Review 5.  Endometriosis: an overview of Cochrane Reviews.

Authors:  Julie Brown; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2014-03-10

6.  Cochrane reviews on acupuncture therapy for pain: A snapshot of the current evidence.

Authors:  Arya Nielsen; L Susan Wieland
Journal:  Explore (NY)       Date:  2019-09-12       Impact factor: 1.775

Review 7.  Acupuncture for pain: an overview of Cochrane reviews.

Authors:  Myeong Soo Lee; Edzard Ernst
Journal:  Chin J Integr Med       Date:  2011-02-27       Impact factor: 1.978

8.  Research Priorities for Endometriosis.

Authors:  Peter A W Rogers; G David Adamson; Moamar Al-Jefout; Christian M Becker; Thomas M D'Hooghe; Gerard A J Dunselman; Asgerally Fazleabas; Linda C Giudice; Andrew W Horne; M Louise Hull; Lone Hummelshoj; Stacey A Missmer; Grant W Montgomery; Pamela Stratton; Robert N Taylor; Luk Rombauts; Philippa T Saunders; Katy Vincent; Krina T Zondervan
Journal:  Reprod Sci       Date:  2016-09-27       Impact factor: 3.060

Review 9.  [Chronic pelvic pain in women].

Authors:  F Siedentopf; M Sillem
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

Review 10.  Complementary and Alternative Medicine for Dysmenorrhea Caused by Endometriosis: A Review of Utilization and Mechanism.

Authors:  Ying Guo; Fang-Yuan Liu; Ying Shen; Jia-Yue Xu; Liang-Zhen Xie; Shi-Ying Li; Dan-Ni Ding; Dan-Qi Zhang; Feng-Juan Han
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.